Abinash Nayak | Cell Biology | Best Researcher Award

Published-on by Indian Scientist

Mr. Abinash Nayak | Cell Biology | Best Researcher Award

Utkal University | India

Abinash Nayak is an emerging postgraduate researcher in Zoology specializing in Cell Biology at Utkal University. His academic and research journey emphasizes understanding cellular mechanisms, particularly in cancer biology. He has actively participated in university-level hands-on workshops and delivered presentations on topics such as “BH3 Mimetics: Unlocking the Apoptotic Code for Cancer Therapy” and “The Art of Cellular Burial: Exploring Efferocytosis” at national conferences. His notable scholarly contribution includes a publication titled “Deciphering the Contributions of Extracellular Vesicles to Cancer Metastasis: Mechanisms and Therapeutic Implications” in Critical Reviews in Oncology/Hematology (Elsevier), which currently represents his sole publication. With an h-index of 1, 1 research document, and initial citations beginning to accumulate, his work reflects the early but significant impact in the field. His research interests encompass cellular communication, apoptosis, extracellular vesicle biology, and their therapeutic implications in oncology. Abinash’s dedication to advancing biomedical science through meticulous research and review writing highlights his potential as a promising young scientist. His contributions not only enhance the understanding of cancer metastasis mechanisms but also provide a foundation for future translational research in cellular therapy. He aspires to continue exploring innovative approaches in cell biology and contribute meaningfully to cancer research.

Profiles: Orcid

Featured Publication

Nayak, A., & Nishank, S. S. (2025). Deciphering the contributions of extracellular vesicles to cancer metastasis: Mechanisms and therapeutic implications. Critical Reviews in Oncology/Hematology.

Bijesh Biswal | Cell Biology | Excellence in Research Award

Published-on by Indian Scientist

Dr. Bijesh Biswal | Cell Biology | Excellence in Research Award

National Institute of Technology Rourkela | India

Dr. Bijesh Kumar Biswal is an Associate Professor at the Cancer Drug Resistance Laboratory, Department of Life Science, National Institute of Technology Rourkela, India. He holds a Ph.D. in Cancer Biology from IIT Madras and has completed postdoctoral research at Rutgers University and Dartmouth College, USA. His research focuses on cancer biology, particularly transcriptional regulation, drug resistance mechanisms, and exosome-mediated drug delivery. Dr. Biswal has authored over 60 publications and has been cited more than 1,100 times, reflecting his significant contribution to the field. He has mentored 3 Ph.D. students and 15 Master’s students, with several ongoing research projects. His work has been recognized with awards such as the Best Faculty Advisor Award from NIT Rourkela and the Early Career Research Award from SERB, DST, New Delhi. Dr. Biswal is a life member of the Indian Association of Cancer Research and the Society of Biochemists India. His research continues to influence cancer therapeutics and drug resistance studies.

Profiles: Google Scholar | Orcid

Featured Publication

Tripathi, S. K., Panda, M., & Biswal, B. K. (2019). Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy. Food and Chemical Toxicology, 125, 566–582.

Tripathi, S. K., & Biswal, B. K. (2020). Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent. Pharmacological Research, 156, 104772.

Panda, M., Tripathi, S. K., & Biswal, B. K. (2021). SOX9: An emerging driving factor from cancer progression to drug resistance. Biochimica et Biophysica Acta (BBA) – Reviews on Cancer, 1875(2), 188517.

Panda, M., & Biswal, B. K. (2019). Cell signaling and cancer: A mechanistic insight into drug resistance. Molecular Biology Reports, 46(5), 5645–5659.

Mao, P., Hever-Jardine, M. P., Rahme, G. J., Yang, E., Tam, J., Kodali, A., Biswal, B., … (2013). Serine/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastoma. PLoS One, 8(11), e81803.